Clinical Trials Browser

Recruiting × Interventional × Hyperinsulinism × Clear all

Fibrosarcoma, Hyperinsulinism, Hypoglycemia, Insulinoma, Adenoma, Islet Cell, Liposarcoma, Neoplasms, Neuroectodermal Tumors, Primitive, Neuroendocrine Tumors

NCT05088798 2025-12-19

18FDOPA HI

Phase 2 Recruiting

100 enrolled

Endocrine

Hyperinsulinism, Hypoglycemia, Infant, Newborn, Diseases, Insulinoma, Glucose Metabolism Disorders

NCT05455619 2025-05-29

Amelia-1

Phase 1/2 Recruiting

52 enrolled

Breast

Breast Neoplasms, Hyperglycemia, Hyperinsulinism, Insulin Resistance

NCT05989347 2025-03-19

Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant with Neoadjuvant Therapy

Phase 1 Recruiting

20 enrolled

Breast

Breast Neoplasms, Hyperinsulinism

NCT02021604 2024-07-16

Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma

Phase 1 Recruiting

250 enrolled

Endocrine

Hyperinsulinism, Hypoglycemia, Insulinoma, Congenital Hyperinsulinism

NCT05753657 2023-03-03

A Pilot Study of Monitoring Insulin Levels and Treating Hyperinsulinemia and Hyperglycemia With Pioglitazone in Patients Treated With Alpelisib for Metastatic Breast Cancer.

Phase EARLY_PHASE1 Recruiting

30 enrolled

Breast

Breast Neoplasms, Hyperinsulinism

Clinical Trials

Tumor HI

18FDOPA HI

Amelia-1

Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant with Neoadjuvant Therapy

Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma

A Pilot Study of Monitoring Insulin Levels and Treating Hyperinsulinemia and Hyperglycemia With Pioglitazone in Patients Treated With Alpelisib for Metastatic Breast Cancer.